RA
Rise Advisors’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
558
+10
| +2% | +$3.89K | 0.09% | 92 |
|
|
2025
Q1 | $238K | Buy |
548
+422
| +335% | +$183K | 0.11% | 78 |
|
|
2024
Q4 | $46.4K | Buy |
126
+1
| +0.8% | +$368 | 0.02% | 245 |
|
|
2024
Q3 | $65.1K | Hold |
125
| – | – | 0.03% | 197 |
|
|
2024
Q2 | $67.6K | Buy |
125
+1
| +0.8% | +$541 | 0.04% | 192 |
|
|
2024
Q1 | $64.5K | Buy |
124
+117
| +1,671% | +$60.9K | 0.03% | 191 |
|
|
2023
Q4 | $3.15K | Hold |
7
| – | – | ﹤0.01% | 422 |
|
|
2023
Q3 | $2.9K | Hold |
7
| – | – | ﹤0.01% | 425 |
|
|
2023
Q2 | $2.95K | Hold |
7
| – | – | ﹤0.01% | 472 |
|
|
2023
Q1 | $3.04K | Hold |
7
| – | – | ﹤0.01% | 516 |
|
|
2022
Q4 | $3.38K | Hold |
7
| – | – | ﹤0.01% | 497 |
|
|
2022
Q3 | $3K | Hold |
7
| – | – | ﹤0.01% | 493 |
|
|
2022
Q2 | $3K | Hold |
7
| – | – | ﹤0.01% | 500 |
|
|
2022
Q1 | $3K | Hold |
7
| – | – | ﹤0.01% | 480 |
|
|
2021
Q4 | $3.02K | Buy |
+7
| New | +$3.02K | ﹤0.01% | 475 |
|